Avobenzone, Homosalate, Octisalate, Octocrylene by Avert Skincare Inc / Inspec solutions LLC Avert Facemist SPF50

Avobenzone, Homosalate, Octisalate, Octocrylene by

Drug Labeling and Warnings

Avobenzone, Homosalate, Octisalate, Octocrylene by is a Otc medication manufactured, distributed, or labeled by Avert Skincare Inc, Inspec solutions LLC. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE- avobenzone, homosalate, octisalate, octocrylene spray 
Avert Skincare Inc

----------

Avert Facemist SPF50

Active Ingredients

Avobenzone 3%

Homosalate 10%

Octisalate 5%

Octocrylene 10%

Purpose

Sunscreen

Uses

  • helps prevent sunburn
  • if used as directed with other sun protections measures (see Directions), decreases the risk of skin cancer and early skin aging caused by the sun

Warnings

For external use only.

Do not use

  • on damaged or broken skin

When using this product

  • keep out of eyes. Rinse with water to remove

Stop use and ask a doctor if

  • rash occurs

Keep out of reach of children.

If swallowed, get medical help or contact a Poison Control Center right away

Directions

  • apply liberally 15 minutes before sun exposure
  • children under 6 months: ask a doctor
  • Hold container 6 to 8 inches from the skin to apply
  • reapply:
  • after 80 minutes of swimming or sweating
  • immediately after towel drying
  • at least every 2 hours
  • ​Sun Protection Measures.​Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen with a Broad Spectrum SPF value of 15 or higher and other sun protection measures including:
  • limit time in the sun, especially from 10 a.m. - 2 p.m.
  • wear long-sleeved shirts, pants, hats and sunglasses

Other Information

  • Protect the product from excessive heat and direct sun
  • May Stain Fabrics

Inactive ingredients

Acrylates/octylacrylamide copolymer, Alcohol Denat., Aloe Barbadensis Leaf Extract, Tocopherol, caprylic/capric triglyceride, diethylhexyl syringylidene malonate, glycerin, Retinyl palmitate, stearoxytrimethylsilane

disclaimer

May stain or damage some fabrics or surfaces

Oxybenzone & Octinoxate free

Reef Safe

Non- Comedogenic

Adverse Reactions

Questions? 1-800-661-5804

principal display panel

LabelUnscented Sunscreen

SPF 50

water resistant 80 minutes

Facemist

BROAD

SPECTRUM

SPF 50

3.38 FL OZ (100 ML)

AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE 
avobenzone, homosalate, octisalate, octocrylene spray
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC: 82603-000
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
OCTOCRYLENE (UNII: 5A68WGF6WM) (OCTOCRYLENE - UNII:5A68WGF6WM) OCTOCRYLENE10 g  in 100 mL
AVOBENZONE (UNII: G63QQF2NOX) (AVOBENZONE - UNII:G63QQF2NOX) AVOBENZONE3 g  in 100 mL
HOMOSALATE (UNII: V06SV4M95S) (HOMOSALATE - UNII:V06SV4M95S) HOMOSALATE5 g  in 100 mL
OCTISALATE (UNII: 4X49Y0596W) (OCTISALATE - UNII:4X49Y0596W) OCTISALATE5 g  in 100 mL
Inactive Ingredients
Ingredient NameStrength
ETHYLHEXYL PALMITATE (UNII: 2865993309)  
STEAROXYTRIMETHYLSILANE (UNII: 9862TW94B2)  
TOCOPHEROL (UNII: R0ZB2556P8)  
ACRYLATE/ISOBUTYL METHACRYLATE/N-TERT-OCTYLACRYLAMIDE COPOLYMER (75000 MW) (UNII: JU3XHR8VWK)  
ALCOHOL (UNII: 3K9958V90M)  
MEDIUM-CHAIN TRIGLYCERIDES (UNII: C9H2L21V7U)  
DIETHYLHEXYL SYRINGYLIDENEMALONATE (UNII: 3V5U97P248)  
GLYCERIN (UNII: PDC6A3C0OX)  
VITAMIN A PALMITATE (UNII: 1D1K0N0VVC)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC: 82603-000-01100 mL in 1 BOTTLE, PLASTIC; Type 0: Not a Combination Product03/15/202212/09/2025
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC Monograph DrugM02003/15/202212/09/2025
Labeler - Avert Skincare Inc (243258452)
Registrant - Avert Skincare Inc (243258452)
Establishment
NameAddressID/FEIBusiness Operations
Inspec solutions LLC081030372manufacture(82603-000)

Revised: 12/2025
 

© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.